Stock listing
Cadrenal Therapeutics, Inc.
Selected listing: CVKD · BOATS · USD · US
Cadrenal Therapeutics, Inc. (BOATS:CVKD), Health Technology. Latest release Oct 7, 2026: Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal…
- Ticker
- BOATS:CVKD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Cadrenal Therapeutics, Inc.
The company focuses on developing innovative therapies to address unmet medical needs. Investors can find more information about its operations and market presence on its dedicated company page.
Latest news from Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
October 6, 2026
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
September 21, 2026
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
September 3, 2026
Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia
August 31, 2026
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
August 13, 2026
Research Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. company profile
View the public company page for Cadrenal Therapeutics, Inc. on 6ix.
Cadrenal Therapeutics, Inc. news
Read company news and market updates connected to Cadrenal Therapeutics, Inc..
Cadrenal Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cadrenal Therapeutics, Inc..